These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11759372)

  • 1. [Liver function test impairment induced by propafenone in a 73 year old woman].
    Arinzon Z; Fridman R
    Harefuah; 2001 Nov; 140(11):1010-3, 1119. PubMed ID: 11759372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatic toxicity of propafenone: a case description].
    La Brocca A
    Ann Ital Med Int; 2002; 17(4):261-4. PubMed ID: 12532566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propafenone-related cholestatic hepatitis in an elderly patient.
    Grieco A; Forgione A; Giorgi A; Miele L; Gasbarrini G
    Ital Heart J; 2002 Jul; 3(7):431-4. PubMed ID: 12189974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute cholestatic hepatitis caused by propafenone. Report of a case and review of the literature].
    Gandolfi A; Rota E; Zanghieri G; Tolomelli S; Bagnulo A; Mengoli M
    Recenti Prog Med; 2001 Mar; 92(3):197-9. PubMed ID: 11320851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Propafenone hepatotoxicity].
    Martín EP; Cervantes JL; Yangüela J
    Rev Esp Enferm Dig; 2004 Oct; 96(10):734-5. PubMed ID: 15537382
    [No Abstract]   [Full Text] [Related]  

  • 6. [Proarrhythmic effects of propafenone in a woman with hepatopathy: is it always a simple drug in clinical practice?].
    Hrovatin E; Piazza R; Brieda M; Dametto E; Zardo F; Burelli C; Cassin M; Nicolosi GL
    Ital Heart J Suppl; 2002 Jul; 3(7):770-5. PubMed ID: 12187639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutropenia and cutaneous lesions secondary to propafenone.
    Couto N; Ferreira M; Reis E
    Eur J Dermatol; 2009; 19(4):365-7. PubMed ID: 19451050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute propafenone toxicity after two exposures at standard dosing.
    Yeung A; Shanks D; Parwana H; Gin K
    Can J Cardiol; 2010; 26(6):209-10. PubMed ID: 20548984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propafenone-induced liver injury: report of a case and review of the literature.
    Mondardini A; Pasquino P; Bernardi P; Aluffi E; Tartaglino B; Mazzucco G; Bonino F; Verme G; Negro F
    Gastroenterology; 1993 May; 104(5):1524-6. PubMed ID: 8482464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propafenone hepatotoxicity: report of a new case and review of the literature.
    Younan LB; Barada KA; Faraj WG; Tawil AN; Jabbour MN; Khoury MY; El-Majzoub NM; Eloubeidi MA
    Saudi J Gastroenterol; 2013; 19(5):235-7. PubMed ID: 24045598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profuse oral secretions after propafenone administration in neonates.
    Piersigilli F; Auriti C; Silvetti MS; Marrocco G; Drago F; Seganti G
    J Pediatr; 2010 Nov; 157(5):856-7. PubMed ID: 20659741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propafenone associated severe central nervous system and cardiovascular toxicity due to mirtazapine: a case of severe drug interaction.
    Rajpurohit N; Aryal SR; Khan MA; Stys AT; Stys TP
    S D Med; 2014 Apr; 67(4):137-9. PubMed ID: 24791374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting propafenone toxicity.
    Alsaad AA; Ortiz Gonzalez Y; Austin CO; Kusumoto F
    BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28446489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propafenone-associated Gross Hematuria: A Case Report and Review of the Literature.
    Chen S; Ding W; Ye J; Wang Z; Zhao X; Cui Y
    Clin Ther; 2019 Aug; 41(8):1614-1620. PubMed ID: 31164244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propafenone-induced drug fever in the absence of agranulocytosis.
    O'Rourke DJ; Palac RT; Holzberger PT; Gerling BR; Greenberg ML
    Clin Cardiol; 1997 Jul; 20(7):662-4. PubMed ID: 9220185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Life-threatening ventricular arrhythmia during simultaneous administration of propafenone and sotatol].
    Gilewski W; Bednarska D; Sinkiewicz W
    Kardiol Pol; 2009 Aug; 67(8):916-20; discussion 921. PubMed ID: 19784892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cholestatic hepatitis following antiarrhythmic propafenone therapy].
    Schuff-Werner P; Kaiser D
    Dtsch Med Wochenschr; 1980 Jan; 105(4):137-8. PubMed ID: 7351197
    [No Abstract]   [Full Text] [Related]  

  • 18. Propafenone in a usual dose produces severe side-effects: the impact of genetically determined metabolic status on drug therapy.
    Mörike K; Magadum S; Mettang T; Griese EU; Machleidt C; Kuhlmann U
    J Intern Med; 1995 Nov; 238(5):469-72. PubMed ID: 7595187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propafenone-induced psoriasis.
    Palleschi GM; Bellandi S; Torchia D
    Clin Exp Dermatol; 2008 Mar; 33(2):209-10. PubMed ID: 18257839
    [No Abstract]   [Full Text] [Related]  

  • 20. Propafenone-induced syncope and atrial pacemaker.
    Wagner V; Nényei Z; Tomcsányi J
    Pacing Clin Electrophysiol; 2014 Feb; 37(2):249-51. PubMed ID: 23844932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.